Skip to main content
Caplight Logo









PrintBio, Inc.

PrintBio, Inc.

Private
Long Island City, New YorkHealthcare & Life Scienceshttps://printbio.com/

Last Round

Grant

Feb 12, 2026

Total Funding Raised

$8.46M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

PrintBio, Inc. is a biotechnology company that develops 3D-bioprinting technology and material science solutions for regenerative medicine, including living tissue implants and programmable surgical meshes.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, 3D Printing, Advanced Materials

Business Model

B2B

Customer Profile

Government Contracts, Hardware Sales

AI Layer

Non-AI

Keywords

surgical meshhernia repairbioprintingmedical deviceadditive manufacturingbiomaterialsregenerative medicine3d printingsurgical implanttissue engineeringmedtechbiofabricationreconstructive surgerybioprinted tissue

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PrintBio, Inc. Comparables

Compare PrintBio, Inc. with similar companies based on industry and business-model similarity.

PrintBio, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
3D Systems
77%
CollPlant Biotechnologies Ltd.
70%
ROKIT Healthcare
67%

PrintBio, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 12, 2026
Corporate FundingFeb 29, 2024
Series AApr 10, 2019

PrintBio, Inc. Investors

Notable investors and investment history

PrintBio, Inc. investors
InvestorRounds
Rapha Capital ManagementCorporate Funding, Series A
ARPA-HGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 24, 2026

    Monthly visitors increased 124% MoM.

  • Apr 21, 2026

    Monthly visitors increased 1085% MoM, reaching 5.9K.

PrintBio, Inc. Filings

Explore SEC and related filing metadata, where available.

PrintBio, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about PrintBio, Inc.'s valuation, stock price, and market status.

Is PrintBio, Inc. a public or private company?

PrintBio, Inc. is a private company.

What is the current stock price of PrintBio, Inc.?

PrintBio, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is PrintBio, Inc. worth (valuation)?

Valuation information for PrintBio, Inc. is not publicly available.

Can I buy PrintBio, Inc. stock?

PrintBio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was PrintBio, Inc.'s last funding round?

PrintBio, Inc.'s most recent funding round was Grant on February 12, 2026.

Who are the main investors in PrintBio, Inc.?

Key investors in PrintBio, Inc. include Rapha Capital Management.

Will PrintBio, Inc. IPO soon?

No public IPO plans have been announced for PrintBio, Inc..

How can I track PrintBio, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PrintBio, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLong Island City, New York
Employee Range4
Year Founded2024
Last FundingFeb 12, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?